APA (7th ed.) Citation

Pfaff, E., Keßler, T., Balasubramanian, G. P., Berberich, A., Schrimpf, D., Wick, A., . . . Sahm, F. (2018). Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation: The NCT Neuro Master Match (N2M2) pilot study. Neuro-Oncology, 20(6), . https://doi.org/10.1093/neuonc/nox216

Chicago Style (17th ed.) Citation

Pfaff, Elke, et al. "Feasibility of Real-time Molecular Profiling for Patients with Newly Diagnosed Glioblastoma Without MGMT Promoter Hypermethylation: The NCT Neuro Master Match (N2M2) Pilot Study." Neuro-Oncology 20, no. 6 (2018). https://doi.org/10.1093/neuonc/nox216.

MLA (9th ed.) Citation

Pfaff, Elke, et al. "Feasibility of Real-time Molecular Profiling for Patients with Newly Diagnosed Glioblastoma Without MGMT Promoter Hypermethylation: The NCT Neuro Master Match (N2M2) Pilot Study." Neuro-Oncology, vol. 20, no. 6, 2018, https://doi.org/10.1093/neuonc/nox216.